About Jake Simson
Jake Simson is a director at Septerna.
Jake Simson reports to the SEC as a director of 6 public companies, including Janux Therapeutics (JANX), Parabilis Medicines (PBLS) and Bicara Therapeutics (BCAX).
Jake Simson first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Jake Simson in the role, so the role may have started earlier or lasted longer.
JI
Janux Therapeutics, Inc.
Director
2021 – 2026 · Public company (JANX)
PI
Parabilis Medicines, Inc.
Director
2026 · Public company (PBLS)
BI
Bicara Therapeutics Inc.
Director
2024 – 2026 · Public company (BCAX)
TI
Tyra Biosciences, Inc.
Director
2021 – 2026 · Public company (TYRA)
DI
DICE Therapeutics, Inc.
Director
2021 – 2023 · Public company (DICE)
Key Colleagues at Startups
The people Jake Simson works with at each company, as listed on that company's latest Form D.
Septerna, Inc. · Form D, Jul 13, 2023
AE
Alan Ezekowitz
Director
RX
Ran Xiao
Executive officer
EB
Elizabeth Bhatt
Executive officer
JT
Jeffrey Tong
Director
AB
Abraham Bassan
Director
JF
Jeffrey Finer
Chief Executive Officer and director
SS
Samira Shaikhly
Executive officer